about
Ethnic comparison of pharmacokinetics of (18)F-florbetaben, a PET tracer for beta-amyloid imaging, in healthy Caucasian and Japanese subjects.Present and future roles of FDG-PET/CT imaging in the management of lung cancer.Exploratory human PET study of the effectiveness of (11)C-ketoprofen methyl ester, a potential biomarker of neuroinflammatory processes in Alzheimer's disease.Clinical impact of (11)C-methionine PET on expected management of patients with brain neoplasm.[FDG-PET on the day after first chemotherapy in malignant lymphoma].[Evaluation of lesions of malignant lymphoma using histograms of regional SUV].Decreased 18F-FDG uptake 1 day after initiation of chemotherapy for malignant lymphomas.Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin's lymphoma.Whole-body distribution and radiation dosimetry of [11C]telmisartan as a biomarker for hepatic organic anion transporting polypeptide (OATP) 1B3.Quantification of osteoblastic activity in epiphyseal growth plates by quantitative bone SPECT/CT.Inter-rater variability of visual interpretation and comparison with quantitative evaluation of 11C-PiB PET amyloid images of the Japanese Alzheimer's Disease Neuroimaging Initiative (J-ADNI) multicenter study.Impact of tissue photon attenuation in small animal cardiac PET imaging.Human whole-body biodistribution and dosimetry of a new PET tracer, [(11)C]ketoprofen methyl ester, for imagings of neuroinflammation.Axillary lymph node accumulation on FDG-PET/CT after influenza vaccination.Visual-statistical interpretation of (18)F-FDG-PET images for characteristic Alzheimer patterns in a multicenter study: inter-rater concordance and relationship to automated quantitative evaluation.Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using 18F-FDG PET/CT.Neoadjuvant triweekly nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for Stage II/III HER2-negative breast cancer: evaluation of efficacy and safety.Small-animal PET imaging of isolated perfused rat heart.18F-FLT PET performs better than 18F-FDG PET in differentiating malignant uterine corpus tumors from benign leiomyoma.18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma.Reduction of [(18)F]fluoromisonidazole uptake after neoadjuvant chemotherapy for head and neck squamous cell carcinoma.[F]FMISO PET/CT as a preoperative prognostic factor in patients with pancreatic cancerUltrafast bone scintigraphy scan for detecting bone metastasis using a CZT whole-body gamma camera
P50
Q34434351-64625714-CE33-4DA8-B1C6-42FA983DD4CDQ38819166-F6FCBD28-CEC1-488B-99BE-3B812CA9E4B3Q38866808-532DD629-834E-4F20-8967-72A420062749Q43241655-45B424A9-B537-41CD-9D91-180F46E3CA5AQ44329947-2B643225-118B-4761-A424-4C82C124A3E2Q44528404-92333629-38FE-4131-A541-8127F83607FAQ45144558-C6A288D6-E829-4C02-AA34-AB679728CA0EQ46265930-4EA744F2-168A-4795-AC93-387AC18D8F5CQ46323496-AA0F14C2-FC29-4806-98BA-99666BD25D73Q47554481-BB53C95F-018A-43A2-A957-36AD43AD8851Q48158298-3849D22C-C1DD-422A-AB37-EBC671EF4E05Q48660459-B0965EAC-C66E-4E77-A581-CA31D68B82BEQ48774111-F26BC1F8-C1A4-4362-899C-24D91149C594Q51176549-E37DF33F-0C29-404A-BEEA-EADA47E57C9FQ51179901-81816988-765F-4DFF-AC20-018F324BBBE7Q52984542-63FB7BB7-C85E-4D8F-84E9-F6D0904AC6FEQ53008476-1823C65B-AC56-46E5-8549-3B9D50FE059DQ53081266-78276E6C-29EB-40F4-96ED-3ABC9D946229Q53175645-7484B3CF-5575-49E7-B248-147C9648A42FQ53216205-AD0E0F26-9742-4CAE-B6DC-96E85F025282Q53318292-E81B3CCA-B92D-4C67-A439-B98E6CC77D95Q64245362-7D236169-59C8-4BBB-98D2-D80BD7C13AE3Q91680832-E0C72619-BB40-484D-82D0-260C599D2A84
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tomohiko Yamane
@ast
Tomohiko Yamane
@en
Tomohiko Yamane
@es
Tomohiko Yamane
@nl
Tomohiko Yamane
@sl
type
label
Tomohiko Yamane
@ast
Tomohiko Yamane
@en
Tomohiko Yamane
@es
Tomohiko Yamane
@nl
Tomohiko Yamane
@sl
prefLabel
Tomohiko Yamane
@ast
Tomohiko Yamane
@en
Tomohiko Yamane
@es
Tomohiko Yamane
@nl
Tomohiko Yamane
@sl
P106
P1153
55242465400
P21
P31
P496
0000-0003-0955-4272
P569
2000-01-01T00:00:00Z